Also trades as: IBIDF (OTC) · $vol 0M
4062.T JPX
Ibiden Co.,Ltd.
1W: +3.8%
1M: -40.9%
3M: -49.2%
YTD: +52.8%
1Y: +81.8%
3Y: +45.6%
5Y: +105.9%
¥12,100.00 ($76.66)
+105.00 (+0.88%)
Weekly Expected Move ±28.7%
¥5166
¥8633
¥12100
¥15567
¥19034
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$416.2B
+12.7% ▲
5Y CAGR: +5.2%
Gross Profit
$127.8B
+14.5% ▲
5Y CAGR: +8.4%
Operating Income
$58.2B
+26.8% ▲
5Y CAGR: +8.5%
Net Income
$63.7B
+89.0% ▲
5Y CAGR: +19.9%
EPS (Diluted)
$107.46
+90.0% ▲
5Y CAGR: -10.2%
EBITDA
$158.7B
+48.2% ▲
5Y CAGR: +18.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $401.1B | $417.5B | $370.5B | $369.4B | $416.2B |
| YoY Growth | +24.0% | +4.1% | -11.3% | -0.3% | +12.7% |
| Cost of Revenue | $281.1B | $290.0B | $268.0B | $257.9B | $288.4B |
| Gross Profit | $120.1B | $127.5B | $102.5B | $111.6B | $127.8B |
| Gross Margin | 29.9% | 30.5% | 27.7% | 30.2% | 30.7% |
| R&D Expenses | $15.7B | $19.7B | $20.2B | $27.5B | $0 |
| SG&A Expenses | $33.5B | $35.5B | $34.7B | $65.7B | $69.6B |
| Operating Expenses | $49.3B | $55.2B | $54.9B | $65.7B | $69.6B |
| Operating Income | $70.8B | $72.4B | $47.6B | $45.9B | $58.2B |
| Operating Margin | 17.7% | 17.3% | 12.8% | 12.4% | 14.0% |
| Interest Expense | $425M | $567M | $841M | $1.3B | $1.4B |
| Income Before Tax | $59.3B | $71.7B | $47.4B | $51.5B | $91.1B |
| Tax Expense | $17.7B | $19.3B | $15.7B | $17.4B | $26.9B |
| Net Income | $41.2B | $52.2B | $31.5B | $33.7B | $63.7B |
| Net Margin | 10.3% | 12.5% | 8.5% | 9.1% | 15.3% |
| EPS (Diluted) | $295.34 | $373.73 | $224.86 | $113.09 | $107.46 |
| EBITDA | $112.5B | $127.3B | $94.4B | $100.2B | $158.7B |
| Shares Outstanding | 140M | 140M | 140M | 295M | 590M |